To check Oneindia News on your Mobile
go to:   http://m.oneindia.in/news/
  •  

Infosys denies rumour on Cap Gemini acquisition

Bangalore, July 11: Indian software major Infosys today deniedtakeover of French IT consulting firm Cap Gemini and brushed reports tothis effect as rumours.

Talking to newsmen at the announcement of the first quarterresults of the company, Infosys CEO and Managing Director SGopalakrishnan said ''we cannot comment on rumours''.

Stating that Infosys was keen on acquisitions, he said it was open for companies both within the country and outside.

Replying to a question he said that subsidiary Infosys Consultingwould continue to be in red for th next three to four quarters as itwas still in investment mode. The loss had come down substantially from10 million dollars to one million dollars, he added.


UNI

Biotechnology major Biocon forays into nephrology space

Bangalore, Mar 09:  Biotechnology major Biocon on Thursday forayed into the nephrology space with the launch of a portfolio of five renal therapy products for the domestic and global markets, which it said was cheaper compared to MNC drug prices. The new immunosuppressants for renal therapy are at least 35-40 per cent cheaper than the MNC drug prices in the similar product category, the company's Marketing Head Rakesh Bamzai said.The Bangalore-headquartered company's Chairman and Managing Director, Kiran Mazumdar-Shaw said.....
User Comments
[ Post Comments ]
Be the first to comment on this article.
Oneindia  Oneindia Login